Literature DB >> 28739185

Novel atherogenic pathways from the differential transcriptome analysis of diabetic epicardial adipose tissue.

V Camarena1, D Sant1, M Mohseni2, T Salerno3, M L Zaleski2, G Wang4, G Iacobellis5.   

Abstract

BACKGROUND AND AIM: To evaluate the epicardial adipose tissue (EAT) transcriptome in comparison to subcutaneous fat (SAT) in coronary artery disease (CAD) and type 2 diabetes (T2DM). METHODS AND
RESULTS: SAT and EAT samples were obtained from subjects with T2DM and CAD (n = 5) and those without CAD with or without T2DM (=3) undergoing elective cardiac surgery. RNA-sequencing analysis was performed in both EAT and SAT. Gene enrichment analysis was conducted to identify pathways affected by the differentially expressed genes. Changes of top genes were verified by quantitative RT-PCR (qRT-PCR), western blot, and immunofluorescence. A total of 592 genes were differentially expressed in diabetic EAT, whereas there was no obvious changes in SAT transcriptome between diabetics and non-diabetics. Diabetic EAT was mainly enriched in inflammatory genes, such as Colony Stimulating Factor 3 (CSF3), Interleukin-1b (IL-1b), IL-6. KEGG pathway analysis confirmed that upregulated genes were involved in inflammatory pathways, such as Tumor Necrosis Factor (TNF), Nuclear Factor-κB (NF-κB) and advanced glycation end-products-receptor advanced glycation end products (AGE-RAGE). The overexpression of inflammatory genes in diabetic EAT was largely correlated with upregulated transcription factors such as NF-κB and FOS.
CONCLUSIONS: Diabetic EAT transcriptome is significantly different when compared to diabetic SAT and highly enriched with genes involved in innate immune response and endothelium, like Pentraxin3 (PTX3) and Endothelial lipase G (LIPG). EAT inflammatory genes expression could be induced by upregulated transcription factors, mainly NF-kB and FOSL, primarily activated by the overexpressed AGE-RAGE signaling. This suggests a unique and novel atherogenic pathway in diabetes.
Copyright © 2017 The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Epicardial adipose tissue; Epicardial fat; Transcriptome

Mesh:

Substances:

Year:  2017        PMID: 28739185     DOI: 10.1016/j.numecd.2017.05.010

Source DB:  PubMed          Journal:  Nutr Metab Cardiovasc Dis        ISSN: 0939-4753            Impact factor:   4.222


  14 in total

Review 1.  Epicardial adipose tissue as a mediator of cardiac arrhythmias.

Authors:  Kiran Haresh Kumar Patel; Taesoon Hwang; Curtis Se Liebers; Fu Siong Ng
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-12-10       Impact factor: 4.733

Review 2.  Cardiovascular risk reduction throughout GLP-1 receptor agonist and SGLT2 inhibitor modulation of epicardial fat.

Authors:  G Iacobellis; M G Baroni
Journal:  J Endocrinol Invest       Date:  2021-10-13       Impact factor: 4.256

Review 3.  Epicardial Adipose Tissue as an Independent Cardiometabolic Risk Factor for Coronary Artery Disease.

Authors:  Nikoleta Karampetsou; Leonidas Alexopoulos; Aggeliki Minia; Vaia Pliaka; Nikos Tsolakos; Konstantinos Kontzoglou; Despoina N Perrea; Paulos Patapis
Journal:  Cureus       Date:  2022-06-01

4.  Targeting Epicardial Fat in Obesity and Diabetes Pharmacotherapy.

Authors:  Gianluca Iacobellis; Sara Basilico; Alexis Elias Malavazos
Journal:  Handb Exp Pharmacol       Date:  2022

5.  Comparative Proteome Analysis of Epicardial and Subcutaneous Adipose Tissues from Patients with or without Coronary Artery Disease.

Authors:  Yu Xing Zhao; Hui Juan Zhu; Hui Pan; Xue Mei Liu; Lin Jie Wang; Hong Bo Yang; Nai Shi Li; Feng Ying Gong; Wei Sun; Yong Zeng
Journal:  Int J Endocrinol       Date:  2019-08-25       Impact factor: 3.257

Review 6.  Receptor for Advanced Glycation End Products (RAGE) and Mechanisms and Therapeutic Opportunities in Diabetes and Cardiovascular Disease: Insights From Human Subjects and Animal Models.

Authors:  Lander Egaña-Gorroño; Raquel López-Díez; Gautham Yepuri; Lisa S Ramirez; Sergey Reverdatto; Paul F Gugger; Alexander Shekhtman; Ravichandran Ramasamy; Ann Marie Schmidt
Journal:  Front Cardiovasc Med       Date:  2020-03-10

7.  Relationship between epicardial fat volume on cardiac CT and atherosclerosis severity in three-vessel coronary artery disease: a single-center cross-sectional study.

Authors:  Yu Sun; Xiao-Gang Li; Kai Xu; Jie Hou; Hong-Rui You; Rong-Rong Zhang; Miao Qi; Li-Bo Zhang; Li-Sheng Xu; Stephen E Greenwald; Ben-Qiang Yang
Journal:  BMC Cardiovasc Disord       Date:  2022-03-04       Impact factor: 2.298

Review 8.  Epicardial adipose tissue in contemporary cardiology.

Authors:  Gianluca Iacobellis
Journal:  Nat Rev Cardiol       Date:  2022-03-16       Impact factor: 49.421

9.  Effects of Semaglutide Versus Dulaglutide on Epicardial Fat Thickness in Subjects with Type 2 Diabetes and Obesity.

Authors:  Gianluca Iacobellis; Alexandra C Villasante Fricke
Journal:  J Endocr Soc       Date:  2020-03-13

Review 10.  Browning Epicardial Adipose Tissue: Friend or Foe?

Authors:  Elisa Doukbi; Astrid Soghomonian; Coralie Sengenès; Shaista Ahmed; Patricia Ancel; Anne Dutour; Bénédicte Gaborit
Journal:  Cells       Date:  2022-03-14       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.